These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37767756)

  • 1. Metered dose inhalers in the transition to low GWP propellants: what we know and what is missing to make it happen.
    Buttini F; Glieca S; Sonvico F; Lewis DA
    Expert Opin Drug Deliv; 2023; 20(8):1131-1143. PubMed ID: 37767756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the Feasibility of Rugose Lipid Microparticles in Pressurized Metered Dose Inhalers with Established and New Propellants.
    Minootan Z; Wang H; Connaughton P; Lachacz K; Carrigy N; Ordoubadi M; Lechuga-Ballesteros D; Martin AR; Vehring R
    AAPS PharmSciTech; 2024 Apr; 25(4):82. PubMed ID: 38600288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues surrounding MDI formulation development with non-CFC propellants.
    Kontny MJ; Destefano G; Jager PD; McNamara DP; Turi JS; Van Campen L
    J Aerosol Med; 1991; 4(3):181-7. PubMed ID: 10147677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Climate is Changing for Metered-Dose Inhalers and Action is Needed.
    Pritchard JN
    Drug Des Devel Ther; 2020; 14():3043-3055. PubMed ID: 32801643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plume Characteristics of Two HFA-Driven Inhaled Corticosteroid/Long-Acting Beta2-Agonist Combination Pressurized Metered-Dose Inhalers.
    Johal B; Murphy S; Tuohy J; Marshall J
    Adv Ther; 2015 Jun; 32(6):567-79. PubMed ID: 26100350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers.
    Liao YH; Brown MB; Jones SA; Nazir T; Martin GP
    Int J Pharm; 2005 Nov; 304(1-2):29-39. PubMed ID: 16181753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.
    Tarara TE; Hartman MS; Gill H; Kennedy AA; Weers JG
    Pharm Res; 2004 Sep; 21(9):1607-14. PubMed ID: 15497686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plume temperature emitted from metered dose inhalers.
    Brambilla G; Church T; Lewis D; Meakin B
    Int J Pharm; 2011 Feb; 405(1-2):9-15. PubMed ID: 21129465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of Methods for Evaluating Particle Stability in Suspension Based Pressurized Metered Dose Inhalers.
    D'Sa D; Chan HK
    Curr Pharm Des; 2015; 21(27):3955-65. PubMed ID: 26290200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical transition to non-CFC pressurized metered dose inhalers.
    Cripps A; Riebe M; Schulze M; Woodhouse R
    Respir Med; 2000 Jun; 94 Suppl B():S3-9. PubMed ID: 10919679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canister valve and actuator deposition in metered dose inhalers formulated with low-GWP propellants.
    Duke DJ; Rao L; Kastengren A; Myatt B; Cocks P; Stein S; Marasini N; Ong HX; Young P
    Int J Pharm; 2023 Dec; 648():123569. PubMed ID: 37925043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants.
    Richards J; Hirst P; Pitcairn G; Mahashabde S; Abramowitz W; Nolting A; Newman SP
    J Aerosol Med; 2001; 14(2):197-208. PubMed ID: 11681651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
    Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
    J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs.
    Kunka R; Andrews S; Pimazzoni M; Callejas S; Ziviani L; Squassante L; Daley-Yates PT
    Respir Med; 2000 Jun; 94 Suppl B():S10-6. PubMed ID: 10919680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPFP, a model propellant for pMDIs.
    Rogueda PG
    Drug Dev Ind Pharm; 2003 Jan; 29(1):39-49. PubMed ID: 12602491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
    Bousquet J; Huchon G; Leclerc V; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():6-12. PubMed ID: 15915007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology.
    Kleinstreuer C; Shi H; Zhang Z
    J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of ethanol on the formation and physico-chemical properties of particles generated from budesonide solution-based pressurized metered-dose inhalers.
    Zhu B; Traini D; Chan HK; Young PM
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1625-37. PubMed ID: 24087854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isothermal microcalorimetry of pressurized systems I: a rapid method to evaluate pressurized metered dose inhaler formulations.
    D'Sa DJ; Lechuga-Ballesteros D; Chan HK
    Pharm Res; 2014 Oct; 31(10):2716-23. PubMed ID: 24760449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol.
    Peyron ID; Britto IL; Benissan LB; Tardieu BZ
    Respir Med; 2005 Apr; 99 Suppl A():S20-30. PubMed ID: 15777605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.